Genesco (NYSE:GCO – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Sunday.
Genesco Stock Performance
Shares of GCO opened at $30.61 on Friday. The company has a current ratio of 1.53, a quick ratio of 0.40 and a debt-to-equity ratio of 0.15. The stock has a 50-day moving average price of $27.46 and a 200-day moving average price of $27.17. The company has a market cap of $343.44 million, a PE ratio of -428.22 and a beta of 2.41. Genesco has a 12-month low of $23.21 and a 12-month high of $37.89.
Genesco (NYSE:GCO – Get Free Report) last posted its quarterly earnings data on Friday, September 6th. The company reported ($0.83) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.12) by $0.29. The company had revenue of $525.19 million during the quarter, compared to the consensus estimate of $512.19 million. Genesco had a negative net margin of 0.03% and a positive return on equity of 0.49%. As a group, equities analysts forecast that Genesco will post 0.66 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Genesco Company Profile
Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.
Further Reading
- Five stocks we like better than Genesco
- What is a Bond Market Holiday? How to Invest and Trade
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- How to Plot Fibonacci Price Inflection Levels
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.